NCT00252967View on ClinicalTrials.gov

Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)

PHASE3TerminatedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

October 31, 2009

Conditions

Atrial FibrillationInflammation

Interventions

DRUG

Atorvastatin

80 mg of Atorvastatin

DRUG

Placebo

Trial Locations (3)

30033

Veteran Administration Medical Center/Emory University, Atlanta

30322

Crawford Long Hospital, Atlanta

The Emory Clinic, Atlanta

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Emory University

OTHER